FeRiva 21/7
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
What the Evidence Says
AI-generated · Qwen 3.6 · methodologyIron, folate, and vitamin B12 are supported by strong evidence for treating anemia and supporting red blood cell production. Vitamin C and zinc provide moderate evidence for enhancing iron absorption and supporting immune function. Overall, these ingredients are well-established for addressing nutritional deficiencies.
AI-generated summary based on research evidence. Not medical advice.
Product Label
Label Data
Supplement Facts — Evidence Check
Other Ingredients
Label Claims — Verification
Product Information
Directions for Use
Dosage and Administration: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple inert tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple inert tablet daily for 7 days. After 28 tablets have been taken a new course maybe started if prescribed.
Warnings & Precautions
Contraindications: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.
Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Keep out of reach of children.
Formulation Notes
Description: FeRiva 21/7 tablets for oral administration is a 28-day iron supplement regiment that consists of 21 red, oval-shaped iron tablets and 7 purple, oval-shaped inert tablets. Each red, oval-shaped iron tablet is debossed with "21" and "7" separated by a line in the middle on the top-side of the tablet and blank on the other side. Each purple, oval shaped inert tablet is blank on both sides of the tablet.
Purple Inert Tablets do not contain any vitamins, minerals or other dietary ingredients. Please see other ingredients section below for the listing of the inert ingredients.
Indications: FeRiva 21/7 is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
Additional Information
RX Only
How Supplied: FeRiva 21/7 tablets blister pack (75854+318-28) contains 21 red iron tablets and 7 purple inert tablets. The listed product number is not a National Drug Code. Instead Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems.
Store betweed 20 degrees - 25 degrees C (68 degrees - 77 degrees F).
Product Details
Research Evidence
Similar Products
This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.